France / Français
Optos announces collaborations in Alzheimer's disease, AMD
Optos Plc, a subsidiary of Nikon Corp., Japan, announced a clinical alliance with Amydis Inc. to develop an eye test to detect Alzheimer's disease and exclusive distribution...
3 days ago - Healio
Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial
Zimura, a complement factor C5 inhibitor, was found to be well tolerated in combination with Lucentis in a phase 2a clinical trial, Ophthotech announced in a press...
6 days ago - Healio
VIDEO: Sustained-release ranibizumab ‘exceeds expectations' for wet AMD
CHICAGO - Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab , at the American Academy of Ophthalmology meeting...
10 days ago - Healio
Calcified Nodules Linked to AMD Progression
Calcified nodules in the retinas of patients with age-related macular degeneration are linked to the progression to advanced stage disease, a study has shown. Medscape Medical News
10 days ago - Medscape
VIDEO: Pearls on using the ForeSee home to detect wet-AMD
CHICAGO - David S. Chin Yee, MD, discusses best practices in using the ForeSee home device to monitor AMD patients' transition from dry to wet forms of the disease at the...
14 days ago - Healio
VIDEO: ForeseeHome helps monitor AMD progression
CHICAGO - Lisa K. Feulner, MD, PhD, discusses the importance of early detection of a transition from dry to wet age-related macular degeneration and how the ForeseeHome program...
20 days ago - Healio
Bispecific Antibody Matches Standard Tx for AMD
Faricimab effective at dosing intervals of both 12 and 16 weeks
20 days ago - MedPageToday
OpRegen shows positive phase 1/2a study results for dry AMD
CHICAGO - OpRegen, a retinal pigment epithelium cell therapy transplant for dry age-related macular degeneration, has shown signs of improving the retina structurally and...
21 days ago - Healio
Metformin May Cut AMD Risk in Diabetes
Almost a 50% risk reduction versus nonusers
21 days ago - MedPageToday
Regenxbio presents phase 1 data for wet AMD gene therapy
CHICAGO - The 6-month results of an ongoing phase 1 study evaluating RGX-314 gene therapy for patients with wet AMD showed positive safety and patient tolerability outcomes...
21 days ago - Healio
Free Registration
The headlines of Master Doctor
Mediterranean diet reduces inflammation and degradation of cartilage in...
Patients with osteoarthritis often rely on medication to manage the painful symptoms of the disease. These drugs often include non-steroidal anti-inflammatory drugs and...
Menopause brings additional complications to sleep disturbances
Women's sleep in midlife can be influenced by general aging and menopause - often at the same time - but health care providers can learn to spot differences to more effectively...
Weekly Health Quiz: Breathing, Hydrogen and Alzheimer's
1 Molecular hydrogen has been scientifically shown to: Increases the pH of the water making it alkaline Have antioxidant effects that specifically target the most harmful free...
Magnetic resonance spectroscopy-based method may help predict prostate...
Metabolic analysis of benign tissue samples from men with prostate cancer allowed researchers to retrospectively predict the aggressiveness of disease and likelihood of...
DNA-Repair-Gene Mutations Linked to More Aggressive Prostate Cancer
Germline mutations in three DNA-repair genes are associated with a greater likelihood of grade reclassification in men on active surveillance for prostate cancer, researchers...